News

WAPO: Medicare, Medicaid to experiment with covering weight loss drugs
Washington Post National Health Reporter Paige Winfield Cunningham discusses how the Trump administration is considering ...
US Plans to Test Medicare, Medicaid Coverage for Weight-Loss Drugs, Washington Post Reports
According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...
Medicare update: Trump admin launching pilot program to cover Ozempic
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...
Medicare, Medicaid plan to experiment with covering weight loss drugs
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
Medscape2d
Primary Care Physicians Increasingly Leave US Medicare
An estimated 4.4% of primary care physicians left Medicare in 2023 — a higher exit rate than specialists — according to a new ...
On This Day: Johnson signs Medicare into law
In 1965, President Lyndon B. Johnson signed Medicare into law, dedicating it to former President Harry Truman, who "planted ...
Weight-loss drugs may be covered by Medicare, Medicaid under experimental program
A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program ...
Health Affairs1dOpinion
Medicare Still Matters
Medicare is on shaky ground in the current policy environment, making it difficult to sustain its accomplishments, much less ...
UnitedHealthcare Medicare Advantage patients won’t have to wait to change coverage
Thousands of Rhode Island seniors and disabled residents no longer covered for non-emergency visits at four local hospitals ...
Medicare and Medicaid move toward covering Ozempic and other weight loss drugs
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
A Medicare experiment could change who gets Ozempic
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
Medicare could save $3.6 billion without risk to older adults, study suggests
The federal government's Medicare program and older adults together spend $4.4 billion a year on care that has low clinical ...